- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-hexamer
- Ligands
- 18 x ZN: ZINC ION(Non-covalent)
- 6 x PLU: LEUCINE PHOSPHONIC ACID(Non-covalent)
PLU.4: 12 residues within 4Å:- Chain A: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, A.451
- Ligands: ZN.1, ZN.2
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:A.451
- Hydrogen bonds: A:K.262, A:D.273, A:L.360
- Water bridges: A:K.250, A:G.335
PLU.11: 12 residues within 4Å:- Chain B: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, A.451
- Ligands: ZN.8, ZN.9
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:A.451
- Hydrogen bonds: B:K.262, B:D.273, B:L.360
- Water bridges: B:G.335
PLU.18: 12 residues within 4Å:- Chain C: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, A.451
- Ligands: ZN.15, ZN.16
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:A.451
- Hydrogen bonds: C:K.262, C:D.273, C:L.360
- Water bridges: C:K.250, C:G.335
PLU.25: 12 residues within 4Å:- Chain D: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, A.451
- Ligands: ZN.22, ZN.23
8 PLIP interactions:8 interactions with chain D- Hydrophobic interactions: D:A.451
- Hydrogen bonds: D:K.250, D:D.255, D:D.255, D:D.255, D:K.262, D:L.360
- Water bridges: D:G.335
PLU.32: 12 residues within 4Å:- Chain E: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, A.451
- Ligands: ZN.29, ZN.30
6 PLIP interactions:6 interactions with chain E- Hydrophobic interactions: E:A.451
- Hydrogen bonds: E:K.262, E:D.273, E:L.360
- Water bridges: E:K.250, E:G.335
PLU.39: 12 residues within 4Å:- Chain F: K.250, D.255, K.262, M.270, D.273, D.332, E.334, T.359, L.360, A.451
- Ligands: ZN.36, ZN.37
5 PLIP interactions:5 interactions with chain F- Hydrophobic interactions: F:A.451
- Hydrogen bonds: F:K.262, F:D.273, F:L.360
- Water bridges: F:G.335
- 18 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
MRD.5: 5 residues within 4Å:- Chain A: A.48, W.82, N.88, A.91, P.461
Ligand excluded by PLIPMRD.6: 6 residues within 4Å:- Chain A: P.44, L.46, T.51, R.52
- Chain F: D.102, L.103
Ligand excluded by PLIPMRD.7: 7 residues within 4Å:- Chain A: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.12: 6 residues within 4Å:- Chain B: A.48, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.13: 7 residues within 4Å:- Chain B: P.44, L.46, K.50, T.51, R.52
- Chain C: D.102, L.103
Ligand excluded by PLIPMRD.14: 8 residues within 4Å:- Chain B: H.233, Y.234, K.235, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.19: 5 residues within 4Å:- Chain C: A.48, W.82, N.88, A.91, P.461
Ligand excluded by PLIPMRD.20: 6 residues within 4Å:- Chain B: D.102, L.103
- Chain C: P.44, L.46, T.51, R.52
Ligand excluded by PLIPMRD.21: 7 residues within 4Å:- Chain C: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.26: 6 residues within 4Å:- Chain D: A.48, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.27: 7 residues within 4Å:- Chain D: P.44, L.46, K.50, T.51, R.52
- Chain E: D.102, L.103
Ligand excluded by PLIPMRD.28: 8 residues within 4Å:- Chain D: H.233, Y.234, K.235, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.33: 5 residues within 4Å:- Chain E: A.48, W.82, N.88, A.91, P.461
Ligand excluded by PLIPMRD.34: 6 residues within 4Å:- Chain D: D.102, L.103
- Chain E: P.44, L.46, T.51, R.52
Ligand excluded by PLIPMRD.35: 7 residues within 4Å:- Chain E: H.233, Y.234, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIPMRD.40: 6 residues within 4Å:- Chain F: A.48, W.82, E.87, N.88, A.91, P.461
Ligand excluded by PLIPMRD.41: 7 residues within 4Å:- Chain A: D.102, L.103
- Chain F: P.44, L.46, K.50, T.51, R.52
Ligand excluded by PLIPMRD.42: 8 residues within 4Å:- Chain F: H.233, Y.234, K.235, P.244, N.295, I.296, V.297, F.349
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Strater, N. et al., Transition state analogue L-leucinephosphonic acid bound to bovine lens leucine aminopeptidase: X-ray structure at 1.65 A resolution in a new crystal form. Biochemistry (1995)
- Release Date
- 1995-07-31
- Peptides
- LEUCINE AMINOPEPTIDASE: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- homo-hexamer
- Ligands
- 18 x ZN: ZINC ION(Non-covalent)
- 6 x PLU: LEUCINE PHOSPHONIC ACID(Non-covalent)
- 18 x MRD: (4R)-2-METHYLPENTANE-2,4-DIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Strater, N. et al., Transition state analogue L-leucinephosphonic acid bound to bovine lens leucine aminopeptidase: X-ray structure at 1.65 A resolution in a new crystal form. Biochemistry (1995)
- Release Date
- 1995-07-31
- Peptides
- LEUCINE AMINOPEPTIDASE: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B